tiprankstipranks
Trending News
More News >
Swiss Re AG (CH:SREN)
:SREN

Swiss Re AG (SREN) AI Stock Analysis

Compare
28 Followers

Top Page

CH:SREN

Swiss Re AG

(SREN)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 4o)
Rating:73Outperform
Price Target:
CHF165.00
▲(24.34% Upside)
Swiss Re AG's strong financial performance, highlighted by robust profitability and a solid balance sheet, is the most significant factor in its stock score. The positive technical indicators and reasonable valuation further support the stock's attractiveness. The earnings call provided a balanced view with strong net income and ROE, though offset by some revenue challenges. Overall, the stock presents a stable investment opportunity with room for growth.
Positive Factors
Strong Net Income and ROE
A strong net income and high ROE indicate effective capital utilization and profitability, enhancing shareholder value and supporting long-term growth.
P&C Business Performance
Strong performance in P&C with a low combined ratio suggests effective risk management and underwriting, contributing to sustainable profitability.
Capital Strength
A high SST ratio reflects robust capital adequacy, ensuring financial stability and resilience against market fluctuations, supporting long-term operations.
Negative Factors
Decline in Group's Insurance Revenue
A decline in insurance revenue can signal challenges in market competitiveness and product demand, potentially impacting future growth prospects.
Life & Health Re Experience Variance
Negative experience variance in Life & Health Re suggests potential issues in risk assessment and pricing, which could affect profitability if not addressed.
Challenges in Casualty Volume
Reduced casualty volumes highlight difficulties in maintaining competitive pricing and risk assessment, which may hinder revenue growth in this segment.

Swiss Re AG (SREN) vs. iShares MSCI Switzerland ETF (EWL)

Swiss Re AG Business Overview & Revenue Model

Company DescriptionSwiss Re AG, together with its subsidiaries, provides wholesale reinsurance, insurance, other insurance-based forms of risk transfer, and other insurance-related services worldwide. The company operates through Property & Casualty Reinsurance, Life & Health Reinsurance, and Corporate Solutions. The Property & Casualty Reinsurance segment underwrites property reinsurance, including property, credit and surety, engineering, aviation, marine, agriculture, retakaful, and facultative reinsurance solutions; and casualty reinsurance, such as liability, motor, worker's compensation, personal accident, management and professional liability, cyber, and facultative reinsurance solutions. The Life & Health Reinsurance segment underwrites life and health insurance products. The Corporate Solutions segment offers standard risk transfer covers and multi-line programs to customized solutions. It serves stock and mutual insurance companies, public sector and governmental entities, mid-sized and large corporations, and individuals. Swiss Re AG was founded in 1863 and is headquartered in Zurich, Switzerland.
How the Company Makes MoneySwiss Re AG primarily generates revenue through its reinsurance operations, which involve underwriting insurance policies for various risks and collecting premiums from ceding companies. The main revenue streams include premiums received from property and casualty reinsurance, life and health reinsurance, and the provision of insurance-based investment products. The company also earns investment income from the management of its substantial investment portfolio, which includes fixed-income securities, equities, and alternative investments. Additionally, Swiss Re engages in strategic partnerships and collaborations with other insurers and financial institutions, enhancing its market presence and enabling it to diversify its revenue sources. The company's strong capital position and risk management capabilities allow it to optimize underwriting performance, contributing further to its profitability.

Swiss Re AG Earnings Call Summary

Earnings Call Date:Aug 14, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 14, 2025
Earnings Call Sentiment Neutral
The earnings call highlighted Swiss Re's strong net income and ROE, improved P&C performance, disciplined pricing, and solid investment results. However, these positives were counterbalanced by declines in insurance revenue, challenges in casualty volumes, and negative experience variance in Life & Health Re. Overall, the highlights and lowlights appear balanced.
Q2-2025 Updates
Positive Updates
Strong Net Income and ROE
Swiss Re reported a net income of USD 2.6 billion for the first half of 2025, resulting in an annualized ROE of 23%. This achievement represents approximately 60% of their full-year net income target of more than USD 4.4 billion.
P&C Business Performance
The P&C businesses benefited from a relatively quiet second quarter in terms of large losses, leading to a strong combined ratio. The P&C reserves were bolstered by a USD 300 million nominal reserving in the first half.
Renewals and Pricing Discipline
The company achieved nominal price increases of 2.3% on its overall portfolio during midyear renewals, with significant increases in property and specialty lines, while reducing casualty volumes by 27%.
Life & Health Re Performance
Life & Health Re reported a net income of USD 839 million, slightly above its pro rata target. The largest portfolios, including U.S. mortality, performed in line with expectations.
Investment Results
The company achieved a return on investment (ROI) of 4.1% in the first half, slightly ahead of last year's 4%, with recurring income standing at USD 2 billion.
Capital Strength
Swiss Re's group SST ratio was estimated at 264% as of July 1, 2025, which is 7 points higher than at the start of the year.
Negative Updates
Decline in Group's Insurance Revenue
The group's insurance revenue amounted to USD 20.9 billion in the first half of 2025, down from USD 22.2 billion last year, driven by factors such as the termination of an external retrocession transaction and nonrenewal of certain businesses.
Life & Health Re Experience Variance
The Life & Health Re segment experienced a negative variance of USD 197 million in the first half due to selective assumption updates in onerous business and volume updates, although actual claims experience was slightly positive.
Challenges in Casualty Volume
Casualty volumes were significantly reduced by 27% due to challenges in achieving rate adequacy and risk assessment.
Company Guidance
During Swiss Re's Half Year 2025 Results Conference Call, the company reported a strong net income of USD 2.6 billion for the first half of the year, achieving an annualized ROE of 23%. The progress is attributed to a robust underwriting performance, particularly in the Property & Casualty (P&C) sector, which saw moderate large losses of under USD 150 million in Q2, predominantly from man-made events. This has led to a 60% realization of their USD 4.4 billion full-year net income target. The P&C Re unit posted a new business CSM of USD 2.2 billion, maintaining the same level as the previous year, and a combined ratio of 81.1%, well below their 85% target. Meanwhile, the Life & Health Re unit generated a net income of USD 839 million, slightly surpassing its pro-rata target. Despite facing challenges in some smaller portfolios, the unit remains on track. The company also reported a modest 3% year-to-date volume growth, with a net price change of negative 1.8%, and aims to reduce its cost run rate by USD 100 million this year, contributing to an overall target of USD 300 million by 2027. The group maintains an SST ratio of 264% as of July 1, 2025, reflecting a resilient capital position.

Swiss Re AG Financial Statement Overview

Summary
Swiss Re AG demonstrates robust financial health with a solid balance sheet and improving profitability. While revenue growth has been inconsistent, the company has managed to enhance its profitability and leverage. Cash flow management is stable, though ensuring consistent revenue growth and efficient investment utilization will be key to future stability and growth.
Income Statement
75
Positive
Swiss Re AG has shown a stable revenue base with some fluctuations over the years. The net profit margin improved to 37.14% in 2024 from 6.46% in 2023, indicating enhanced profitability. However, revenue decreased significantly from 2023 to 2024. EBIT margins have been inconsistent, with EBIT in 2024 being zero. The overall trend shows recovery from previous losses, yet maintaining consistent revenue growth remains a challenge.
Balance Sheet
80
Positive
The company's debt-to-equity ratio has improved over time, showing better leverage management, with a ratio of 0.31 in 2024. The equity ratio has remained stable, indicating a strong balance sheet. Return on Equity (ROE) increased significantly to 14.03% in 2024, highlighting improved shareholder returns. The financial stability is evident, but attention to asset management is needed due to fluctuating total assets.
Cash Flow
70
Positive
Operating cash flow showed a decline from 2023 to 2024, but free cash flow remained positive. The free cash flow to net income ratio improved, indicating better cash generation relative to profit. However, negative investing cash flow suggests a need for careful investment management. The cash flow situation is stable, but there is room for improvement in operational efficiency.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue21.96B8.72B49.73B46.04B46.74B43.34B
Gross Profit21.96B12.37B49.46B46.04B46.74B43.34B
EBITDA0.004.27B-23.00M1.64B-573.00M115.00M
Net Income2.38B3.24B3.21B472.00M1.44B-878.00M
Balance Sheet
Total Assets135.34B127.23B179.58B170.68B181.57B182.62B
Cash, Cash Equivalents and Short-Term Investments0.0088.64B88.38B85.61B4.15B4.70B
Total Debt8.47B7.26B9.82B11.04B11.19B11.74B
Total Liabilities111.27B103.99B163.21B157.87B10.32B11.58B
Stockholders Equity23.93B23.11B16.15B12.70B23.57B27.14B
Cash Flow
Free Cash Flow0.003.13B4.09B2.93B4.10B5.39B
Operating Cash Flow0.003.13B4.09B2.93B4.10B5.39B
Investing Cash Flow0.00-407.00M-362.00M-2.34B-2.14B-7.72B
Financing Cash Flow0.00-2.97B-3.22B-1.24B-2.10B-2.50B

Swiss Re AG Technical Analysis

Technical Analysis Sentiment
Negative
Last Price132.70
Price Trends
50DMA
141.38
Negative
100DMA
143.46
Negative
200DMA
143.01
Negative
Market Momentum
MACD
-3.10
Negative
RSI
43.02
Neutral
STOCH
89.24
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CH:SREN, the sentiment is Negative. The current price of 132.7 is below the 20-day moving average (MA) of 133.73, below the 50-day MA of 141.38, and below the 200-day MA of 143.01, indicating a bearish trend. The MACD of -3.10 indicates Negative momentum. The RSI at 43.02 is Neutral, neither overbought nor oversold. The STOCH value of 89.24 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CH:SREN.

Swiss Re AG Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
CHF85.12B16.9223.97%4.66%-7.33%17.93%
73
Outperform
CHF35.82B12.1517.22%4.52%-4.94%-5.71%
70
Outperform
CHF2.06B13.756.06%3.38%-1.58%4.07%
68
Neutral
CHF8.94B20.394.09%-9.11%73.67%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
68
Neutral
CHF25.87B22.0217.11%3.83%-1.65%10.05%
59
Neutral
CHF10.64B19.443.40%-1.57%95.56%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CH:SREN
Swiss Re AG
132.70
7.87
6.30%
CH:BALN
Baloise Holding AG
198.00
41.13
26.22%
CH:HELN
Helvetia Holding AG
208.60
66.14
46.43%
CH:SLHN
Swiss Life Holding AG
920.00
252.67
37.86%
CH:ZURN
Zurich Insurance Group
601.20
89.21
17.42%
CH:VAHN
Vaudoise Assurances Holding SA
710.00
238.10
50.46%

Swiss Re AG Corporate Events

Swiss Re Targets USD 4.5 Billion Profit in 2026 with Strategic Enhancements
Dec 5, 2025

Swiss Re has announced its strategic goals for 2026, aiming for a group profit of USD 4.5 billion, supported by a renewed strategy that emphasizes disciplined execution and leveraging AI to enhance productivity and decision-making. The company plans to introduce a sustainable annual share buyback program starting in 2026, contingent on achieving a group profit of more than USD 4.4 billion in 2025. Swiss Re has largely completed its review of underperforming portfolios in Life & Health Reinsurance, with an estimated impact on IFRS pre-tax profit of USD 250 million in the fourth quarter. The group maintains its targets for return on equity and dividend growth, while also focusing on reducing operating expenses by USD 300 million by 2027.

Swiss Re Appoints Nicole Pieterse as Chief People Officer
Dec 4, 2025

Swiss Re has announced the appointment of Nicole Pieterse as the new Chief People Officer, effective January 1, 2026, succeeding Cathy Desquesses. Pieterse, who has been with Swiss Re since 2015 and currently serves as Head of Human Resources at Property & Casualty Reinsurance, is recognized for her extensive leadership experience in HR within the financial services industry. This leadership change is seen as a strategic move to continue advancing Swiss Re’s personnel strategy, with the company’s executives expressing confidence in Pieterse’s ability to contribute to its ongoing transformation and success.

Swiss Re Institute Reports on Global Economic Shifts and Insurance Industry Outlook
Nov 19, 2025

Swiss Re Institute’s latest report highlights significant structural changes in the global economy driven by increased government spending, industrial policy, aging populations, and artificial intelligence. These factors are reshaping the risk landscape and impacting global GDP growth, which is expected to stabilize at around 2.5% in the coming years. The insurance industry is poised to benefit from these changes, with global insurance premiums projected to grow by 2.3% annually. However, challenges such as high inflation, fiscal dominance, and potential inefficiencies in industrial policy pose risks. The aging population is shifting demand towards longevity and health coverage, while AI is transforming insurance workflows. Despite these challenges, the insurance market remains robust, with strong profitability and high solvency ratios.

Swiss Re Reports Strong Nine-Month Profit Growth in 2025
Nov 14, 2025

Swiss Re reported a significant profit increase to USD 4.0 billion for the first nine months of 2025, driven by strong underwriting results and solid investment returns. The Property & Casualty Reinsurance division notably improved its combined ratio, benefiting from lower natural catastrophe losses, while Corporate Solutions and Life & Health Reinsurance also contributed positively, despite some challenges. The company’s robust financial performance underscores its strategic focus on underwriting quality and resilience, positioning it well to achieve its full-year profit target.

Swiss Re: Energy Transition to Reshape Global Risk Markets
Nov 5, 2025

Swiss Re’s latest report highlights the significant impact of the global energy transition on risk markets, with investments in energy transition, climate mitigation, and adaptation expected to exceed USD 80 trillion by 2040. The report projects that renewable energy capacity will nearly double by 2030, generating substantial insurance premiums, particularly in Asia-Pacific and Europe. As renewable portfolios mature, insurance needs are shifting towards long-term operational resilience, with new claims trends necessitating closer integration between underwriting and real-world data.

Swiss Re’s Sigma Report: Silver Economy’s Impact on Life Insurance
Oct 22, 2025

Swiss Re’s latest sigma report highlights the transformative impact of the ‘Silver Economy’ on the life insurance industry, driven by an aging population, declining birth rates, and wealth concentration among seniors. By 2050, a significant portion of the population in industrialized countries will be over 65, necessitating a shift in life insurers’ focus from income replacement to wealth planning and personal care financing. This demographic shift presents opportunities for insurers to innovate in product design and delivery, addressing the needs of retirees who face the risk of outliving their savings. The report emphasizes the importance of developing new financial products, such as longevity risk distribution pools and cancer-specific insurance, to meet the evolving demands of an aging population, while also highlighting the growing pressure on long-term care services.

Swiss Re Study: GLP-1 Medications Could Significantly Reduce Mortality by 2045
Sep 17, 2025

Swiss Re’s recent study highlights the potential impact of GLP-1 medications on reducing mortality rates in the USA and UK by 2045, assuming widespread use and lifestyle changes. The study emphasizes the importance of lifestyle modifications alongside medication use to achieve significant mortality reductions, with implications for insurers in risk assessment and benefit claims development.

Swiss Re Highlights Resilience Amid Global Risks at Monte Carlo Meeting
Sep 8, 2025

Swiss Re emphasizes the importance of a holistic approach to maintaining resilience amid complex risks, highlighting the role of AI in improving risk assessment and underwriting quality. The company underscores the urgency of preventive measures against natural disasters and stresses the need for collaboration between public and private sectors to mitigate risks. Geopolitical uncertainties and fragmentation pose challenges to the re/insurance market, affecting risk assessment and causing volatility. Swiss Re views re/insurance as a stabilizing force during global upheavals, supporting economic recovery and resilience.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 22, 2025